To the Editor
Causes of hospital admission have been studied in sickle cell disease 1, 2 . However, only two reports (one from Iran and the other from Sardinia), limited to patients with TM, have previously described the causes of hospital admission in thalassemia patients 3, 4 . We aimed at investigating the prevalence of causes of hospital admission in both TM and TI patients during the period from 1995 to 2015 in a tertiary care center in Beirut, Lebanon.
The study was approved by the Institutional Review Board of the American University of Beirut.
The patients' electronic medical records were queried using the keyword "thalassemia". Patients with TM were more likely to have a longer hospital stay per admission when compared to patients with TI (6.3 days versus 3.6 days, respectively; p = 0.034). Overall, the three most common causes of hospitalization were transfusion therapy (54.6%), infection (12.2%), and chemotherapy (7.3%). In TM, the most common causes of hospital admission were transfusion therapy (66.4%), infection (9.6%), and bone marrow transplantation (7.2%); whereas in TI, these were transfusion therapy (36.3%), chemotherapy (18.8%), and infection (16.3%). Table 1 compares the characteristics of the TM and TI patients admitted to the hospital and summarizes the most common causes of hospital admission in both TM and TI cohorts.
In a linear regression model of all the hospital admissions, including age, sex, type of thalassemia, splenectomy status, aspirin therapy, iron chelation therapy, serum ferritin, and hemoglobin, a longer hospital stay was only associated with increasing age (p = 0.001).
Transfusion therapy was the most common cause of hospital admission in both TM and TI patients. Second to transfusion therapy, infections were the most common cause of hospital admission among TM patients. Although splenectomy was the most common reason for hospital admission in the Iranian study 3 , it was the fourth most common cause of hospitalization in TM patients in our cohort. Splenectomy was not found to be associated with a longer length of hospital stay in our cohort of patients. Chemotherapy was the second most common reason for hospitalization in TI patients. This is particularly evident in patients with TI as well reflected by our dataset whereby all admissions for malignancy-related chemotherapy were exclusively in TI patients.
This study is the first to examine the causes of hospital admission among patients with β-thalassemia in Lebanon. It is the first in the literature to investigate such causes in patients belonging to the TI subset. Infections are a major cause of hospitalization in both TM and TI.
